Drugs covered by patent . Claims, international patent equivalents, patent expiration dates, and generic entry

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Hisamitsu Pharm Co	SALONPAS	menthol; methyl salicylate	PATCH;TOPICAL	022029-001	Feb 20, 2008		OTC	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y				⤷ Try a Trial
Hisamitsu Pharm Co	SALONPAS	menthol; methyl salicylate	PATCH;TOPICAL	022029-002	Nov 5, 2012		OTC	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y				⤷ Try a Trial
Glaxosmithkline	OJJAARA	momelotinib dihydrochloride	TABLET;ORAL	216873-001	Sep 15, 2023		RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y	Y		FOR THE TREATMENT OF INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS	⤷ Try a Trial
Glaxosmithkline	OJJAARA	momelotinib dihydrochloride	TABLET;ORAL	216873-002	Sep 15, 2023		RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y	Y		FOR THE TREATMENT OF INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS	⤷ Try a Trial
Glaxosmithkline	OJJAARA	momelotinib dihydrochloride	TABLET;ORAL	216873-003	Sep 15, 2023		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y	Y		FOR THE TREATMENT OF INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS	⤷ Try a Trial
Genentech Inc	ESBRIET	pirfenidone	CAPSULE;ORAL	022535-001	Oct 15, 2014	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				METHOD FOR ADMINISTERING PIRFENIDONE TO REDUCE DRUG INTERACTIONS WITH FLUVOXAMINE	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate